Biocon

(27 search results)

Biocon shares drop 6% after USFDA inspection of Malaysian unit
Biocon shares down 5% on 30% dip in Q1 profit
Why Cancer Is The New Cardiology For Hospital Chains
Biocon shares jump 7% on strong Q4, dividend declaration
Serum Institute to double its investment in Biocon subsidiary to $300 mn
Biocon says 'all product approvals are legitimate' in bribery case for insulin approval
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
Biocon developing 20 biosimilar products for global markets
Biocon wins US patent battle against Sanofi on insulin biosimilar
Nykaa’s Falguni now richer than Havells, Marico, Eicher and Biocon owners